The Influence of Anterior Chamber Fluid Mediators on the Success Rate of Trabeculectomy
NCT ID: NCT01115218
Last Updated: 2018-11-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
62 participants
OBSERVATIONAL
2009-10-31
2012-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multidrug Resistance After Trabeculectomy With Mitomycin C
NCT00449631
Trabeculectomy Versus Canaloplasty to Treat Glaucoma
NCT00854256
Trabeculopuncture as Predictive Test for the Success of Ab Interno Trabeculectomy
NCT06523751
Effectiveness of a Procedure for Previously Failed Glaucoma Surgery
NCT00347789
Trabeculectomy Versus Canaloplasty
NCT01228799
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Glaucoma patients
Trabeculectomy
Trabeculectomy with mitomycin C
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Trabeculectomy
Trabeculectomy with mitomycin C
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 60 eyes of 60 patients, The ratio of female / male is not involved.
* Eye pressure under local therapy: 20mmHg and above (corrected with pachymetry table).
* age of at least 18 years
* less than 50yl anterior chamber fluid could be collected during the operation.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Cologne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Arno Hueber
Arno Hueber
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Eye Hospital, University of Cologne
Cologne, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MeVeTra-2009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.